Clinical trial

Effect of Food Composition on Postprandial Insulin Secretion in Neonatal Diabetes

NCT02921906

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention High protein meal Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention High carbohydrate meal Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Paracetamol Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Fasting state - sulphonylurea only Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effect of Food Composition on Postprandial Insulin Secretion in Neonatal Diabetes

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-06-01

PhaseNA

Conditions

Neonatal Diabetesunresolved

Interventions

High protein mealOTHER

High carbohydrate mealOTHER

ParacetamolDRUG

Fasting state - sulphonylurea onlyOTHER

Sponsors & collaborators

Royal Devon and Exeter NHS Foundation Trustlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02921906 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.